Prochymal,* an adult mesenchymal stem cell therapy, shows promise for end-stage graft-versus-host disease (GvHD) in paediatric patients,
2019 ◽
pp. 111-141
2016 ◽
Vol 20
(1)
◽
pp. 63
◽
2012 ◽
Vol 45
(3)
◽
pp. 257-268
◽